Linnaeus Therapeutics, Inc.
Biotechnology company · Haddonfield, New Jersey, United States
Linnaeus Therapeutics, Inc. is a biotechnology company headquartered in Haddonfield, New Jersey, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $999,960 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2026.
Linnaeus Therapeutics at a glance
What does Linnaeus Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $999,960 in total (2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $5 million sold (2026).
Frequently asked questions about Linnaeus Therapeutics
Where is Linnaeus Therapeutics headquartered?
Linnaeus Therapeutics, Inc. is headquartered in Haddonfield, New Jersey, United States.
What does Linnaeus Therapeutics do?
Linnaeus Therapeutics, Inc. is a biotechnology company.
When was Linnaeus Therapeutics founded?
The earliest incorporation on record for Linnaeus Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Implicyte, Inc.Haddonfield, New Jersey, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences